Literature DB >> 2770706

Inhibition of acetylcholine storage by acetylcholine analogs in vitro.

G A Rogers1, S M Parsons.   

Abstract

Forty-five acetylcholine (AcCh) analogs were chemically synthesized and characterized. They and two commercially available analogs were tested for the ability to inhibit active transport of AcCh by synaptic vesicles purified from the electric organ of Torpedo californica. A range of potencies greater than 4 orders of magnitude was found. A quaternary nitrogen and the presence of the carbonyl group are important to potency. The addition of hydrophobic groups to both ends of isonipecotic acid yielded the most potent analogs, which exhibited a nearly 1000-fold increase in potency relative to AcCh. The probable conformation of AcCh bound by the transporter has been deduced and confirmed by the synthesis of a potent rigid analog based on 2-amino-9-fluorenone. A potent analog was shown to be a competitive inhibitor with respect to AcCh, thus confirming that its site of action is the transporter active site. The structure-activity data clearly distinguish the binding site for AcCh from the site for vesamicol [(--)-(trans)-2-(4-phenylpiperidino)cyclohexanol], which is a noncompetitive inhibitor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2770706

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  3 in total

1.  Specificity of the rat vesicular acetylcholine transporter.

Authors:  Myung-Hee Kim; Mei Lu; Gary Rogers; Stanley Parsons; Louis B Hersh
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Search for the acetylcholine and vesamicol binding sites in vesicular acetylcholine transporter: the region around the lumenal end of the transport channel.

Authors:  Parul Khare; Anuprao Mulakaluri; Stanley M Parsons
Journal:  J Neurochem       Date:  2010-10-12       Impact factor: 5.372

3.  Characterization of [3H]vesamicol binding in rat brain preparations.

Authors:  E M Meyer; S O Bryant; R H Wang; R J Watson
Journal:  Neurochem Res       Date:  1993-10       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.